Related Experiment Video
Updated: Sep 27, 2025

Measuring the Carotid to Femoral Pulse Wave Velocity Cf-PWV to Evaluate Arterial Stiffness
Published on: May 3, 2018
Covid-19 Effects on ARTErial StIffness and Vascular AgeiNg: CARTESIAN Study Rationale and Protocol
Rosa Maria Bruno1, Bart Spronck2,3, Bernhard Hametner4
1INSERM U970 Team 7, Paris Cardiovascular Research Centre - PARCC, University Paris Descartes, AP-HP, Pharmacology Unit, Hôpital Européen Georges Pompidou, 56 Rue Leblanc, Paris 75015, France.
Insights
The CARTESIAN study investigates how COVID-19 impacts vascular ageing, assessing early vascular ageing (EVA) markers six and twelve months post-infection. This research aims to understand COVID-19
Area of Science:
- Cardiovascular Medicine
- Infectious Diseases
- Vascular Biology
- Epidemiology
Background:
- COVID-19, a novel coronavirus pneumonia, has caused a global pandemic since December 2019.
- While primarily respiratory, COVID-19 significantly affects the cardiovascular system.
- The long-term vascular consequences of COVID-19 remain largely uncharacterized.
Purpose of the Study:
- To evaluate the presence of Early Vascular Ageing (EVA) 6 and 12 months after COVID-19 infection.
- To assess the impact of COVID-19 disease severity on EVA.
- To explore the influence of psychosocial factors, comorbidities, and treatments on COVID-19-induced EVA.
Main Methods:
- The CARTESIAN study is the first international multicentre initiative on COVID-19's effects on vascular ageing biomarkers.
- Utilizes non-invasive cardiovascular measurements: carotid-femoral pulse wave velocity, central blood pressure, carotid ultrasound, and brachial flow-mediated dilatation.
- Enrolls over 2500 individuals across 43 centers in 21 countries.
Main Results:
- This section is to be filled upon study completion.
Conclusions:
- The CARTESIAN study will provide novel insights into the relationship between COVID-19, disease severity, and early vascular ageing.
- Findings may inform future diagnostic and care strategies, focusing on vulnerable populations.
- Establishes a large cohort for understanding post-COVID-19 vascular health.
Abstract:
In December 2019, an outbreak of pneumonia caused by a novel Coronavirus (COVID-19) spread rapidly worldwide. Although the clinical manifestations of COVID-19 are dominated by respiratory symptoms, the cardiovascular system is extensively affected at multiple levels. Due to the unprecedented consequences of the COVID-19 pandemic, the ARTERY society decided to launch the Covid-19 effects on ARTErial StIffness and vascular AgeiNg (CARTESIAN) study - the first international multicentre study into the effects of COVID-19 on non-invasive biomarkers of vascular ageing. The main study objective is to evaluate the presence of Early Vascular Ageing (EVA) 6 and 12 months after COVID-19 infection. Secondary objectives are to study the effect of COVID-19 disease severity on EVA, to investigate the role of psychosocial factors in COVID-19 induced EVA, and to investigate the potential modifying effect of comorbidities and chronic treatments. In the CARTESIAN study, a broad array of cardiovascular measurements, including carotid-femoral pulse wave velocity, central blood pressure, carotid ultrasound, brachial flow-mediated dilatation, will be performed. To date, 43 centres from 21 countries have agreed to participate, with an expected study population of >2500 individuals. To our knowledge, CARTESIAN will be the first study to provide insight into the relationship between COVID-19, its severity, and early vascular ageing in a large cohort, potentially enabling future care and diagnostics to be more focused on the most vulnerable.
Related Concept Videos
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Coronary Artery Disease I: Introduction
Atherosclerosis I: Introduction
Atherosclerosis III: Management
The Effect of Aging on Tissues
Peripheral Artery Disease I: Introduction

